Equities

Rimrock Gold Corp

RMRK:PKC

Rimrock Gold Corp

Actions
  • Price (USD)0.0004
  • Today's Change0.00 / 0.00%
  • Shares traded470.00k
  • 1 Year change+33.33%
  • Beta0.6499
Data delayed at least 15 minutes, as of May 31 2024 20:37 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Rimrock Gold Corp. is engaged in the research, development, and sale of cannabidiol (CBD) products on a global scale. The Company is focused on developing and marketing a line of CBD oils and hemp extracts. Its products include CBD oils, creams, hemp products, and CBD coffee infused with resveratrol. The Company, through its wholly owned subsidiary, Acqua Cannabis Corp. (Acqua Cannabis), has launched Acqua CBD Coffee infused with resveratrol through its partnership with Vera Roasting. Acqua Cannabis has also entered the cannabis, cannabinoid, and hemp market with a mandate to market a range of CBD oils and hemp extracts in various forms. The Company has also entered into the Nicotinamide Mononucleotide (NMN) market with the introduction of Astound NMN brand.

  • Revenue in USD (TTM)0.00
  • Net income in USD-764.61k
  • Incorporated2007
  • Employees1.00
  • Location
    Rimrock Gold Corp3651 LINDELL RD, SUITE #D155LAS VEGAS 89103United StatesUSA
  • Phone+1 (800) 854-7970
  • Websitehttps://www.rimrockgold.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cannabis Suisse Corp30.00k-254.75k987.43k--------32.91-0.0057-0.00570.0007-0.01030.0675-------57.35-149.71-238.71--8.37-39.11-849.17-427.20---13.573.38--28.709.00-87.10------
Limitless X Holdings Inc14.21m-8.40m1.00m12.00------0.0705-2.10-2.103.58-3.513.731.7714.401,184,068.00-220.35------77.76---59.15--0.0173-9.02-----65.83---60.80------
CTT Pharmaceutical Holdings Inc0.00-1.67m1.03m0.00--0.5777-----0.0822-0.08220.000.03460.00-------317.2813.49-448.83304.48------------0.00-------3,454.52------
Herborium Group, Inc.340.33k-318.65k1.09m2.00------3.21-0.3492-0.34920.3672-1.162.323.8925.94---216.97-490.56----58.3156.36-93.63-186.810.0331-39.14----19.45-18.15120.44------
GRI Bio Inc0.00-12.77m1.14m4.00--0.345-----26.90-26.900.000.87530.00----0.00-382.23-192.93-869.57-353.99-------37,650.49---16.800.00-------85.61--29.46--
Rimrock Gold Corp0.00-764.61k1.15m1.00---------0.0104-0.01040.00-0.000080.00-------187.26-236.34-1,424.92-366.85-------83,418.52---1.481.12------30.55------
Health Advance Inc-100.00bn-100.00bn1.19m3.00--0.3026----------0.0212----------------------------0.0356--100.00---21.75------
Respirerx Pharmaceuticals Inc0.00-2.17m1.21m2.00---------0.014-0.0140.00-0.04120.00----0.00-2,255.78-2,491.69---------------2.90---------12.78------
Vestiage Inc0.00-21.76k1.22m0.00---------0.0004-0.00040.00-0.00110.00-------4,945.46---------------------------102.30------
Yield10 Bioscience Inc300.00k-13.15m1.23m29.00------4.09-146.30-146.301.06-123.900.0627----10,344.83-274.51-91.26-2,396.54-108.09-----4,381.67-2,279.74---------86.67-35.94-6.55--1.84--
Bespoke Extracts Inc785.45k-1.48m1.30m10.00------1.66-0.1458-0.14580.0774-0.16962.0655.9934.7378,545.00-388.21------43.69---188.79--0.0612-135.42----22,933.72--63.98------
Sativus Tech Corp0.00-68.00k1.35m-----------0.0483-0.04830.00-0.52380.00-------18.8325.48----------------5.41------78.78------
Aoxing Pharmaceutical Company Inc30.11m-1.46m1.36m339.00--0.016--0.0453-0.0192-0.01920.39510.25070.4962.322.56---2.41-14.54-7.06-35.4576.1968.51-4.85-37.690.73680.33870.6052--26.8837.20-62.49---38.80--
LadRx Corp0.001.66m1.37m2.000.80143.960.8170--3.443.440.000.69730.00----0.0096.28-58.97---78.44------------0.00------106.96------
Data as of May 31 2024. Currency figures normalised to Rimrock Gold Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.